FDA Approved: CORDRAN — Supplemental Application (Almirall, LLC)

View source ↗

Summary

FDA approved a supplemental application for CORDRAN (flurandrenolide) filed by Almirall, LLC, likely affecting labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Dermatitis

Drugs mentioned

• CORDRAN (FLURANDRENOLIDE)

Snippet

SUPPL AP for CORDRAN (FLURANDRENOLIDE)